Results 101 to 110 of about 256,609 (339)
Left ventricular reverse remodelling predicts long‐term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry
European Journal of Heart Failure, 2018 To explore whether left ventricular reverse remodelling (LVRR) is a predictor of outcomes in patients with functional mitral regurgitation (FMR) undergoing MitraClip procedure.M. Adamo, C. Godino, C. Giannini, A. Scotti, R. Liga, S. Curello, C. Fiorina, E. Chiari, G. Chizzola, Alessandro Abbenante, E. Visco, L. Branca, F. Fiorelli, E. Agricola, S. Stella, C. Lombardi, A. Colombo, A. Petronio, M. Metra, F. Ettori +19 moresemanticscholar +1 more sourceEmployment of artificial intelligence for an unbiased evaluation regarding the recovery of right ventricular function after mitral valve transcatheter edge‐to‐edge repair
European Journal of Heart Failure, EarlyView.Impact of mitral transcatheter edge‐to‐edge repair (M‐TEER) on left and right heart function. IQR, interquartile range; LA, left atrial; RVEF, right ventricular ejection fraction; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion. Abstract Aims
Long‐standing severe mitral regurgitation (MR) leads to left atrial Vera Fortmeier, Amelie Hesse, Teresa Trenkwalder, Márton Tokodi, Attila Kovács, Elena Rippen, Jule Tervooren, Michelle Fett, Gerhard Harmsen, Shinsuke Yuasa, Moritz Kühlein, Héctor Alfonso Alvarez Covarrubias, Moritz von Scheidt, Ferdinand Roski, Muhammed Gerçek, Tibor Schuster, N. Patrick Mayr, Erion Xhepa, Karl‐Ludwig Laugwitz, Michael Joner, Volker Rudolph, Mark Lachmann +21 morewiley +1 more sourceCardiac resynchronization therapy for enabling guideline‐directed medical therapy optimization in heart failure
European Journal of Heart Failure, EarlyView.Cardiac resynchronization therapy (CRT) as an enabler for guideline‐directed medical therapy (GDMT) in the Swedish Heart Failure Registry (SwedeHF). The figure summarizes the selection of the study population, changes in GDMTs and loop diuretic use/doses from baseline to 1.5‐year follow‐up in patients receiving versus not receiving CRT, and reports the Daniela Tomasoni, Lina Benson, Paolo Gatti, Alessandro Villaschi, Charlotta Ljungman, Marco Metra, Raffaele Scorza, Frieder Braunschweig, Michael Melin, Giuseppe Rosano, Michael Böhm, Javed Butler, William T. Abraham, Wilfried Mullens, Fredrik Gadler, Cecilia Linde, Lars H. Lund, Gianluigi Savarese +17 morewiley +1 more sourceTowards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance
Journal of Cardiovascular Magnetic Resonance, 2008 Cardiovascular magnetic resonance (CMR) is increasingly used to assess patients with mitral regurgitation. Its advantages include quantitative determination of ventricular volumes and function and the mitral regurgitant fraction, and in ischemic mitral ...Firmin David N, Mohiaddin Raad H, Rahman-Haley Shelley, Symmonds Karen, Wage Ricardo, Chan KM John, Pepper John R, Pennell Dudley J, Kilner Philip J +8 moredoaj +1 more sourceLiver stiffness measurement for non‐invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot study
European Journal of Heart Failure, EarlyView.Liver stiffness measurement for central venous pressure assessment. AUC, area under the curve; BMI, body mass index; CI, confidence interval; CVP, central venous pressure; HF, heart failure; LSM, liver stiffness measurement; LVEF, left ventricular ejection fraction. Abstract Aims
Central venous pressure (CVP) is an important variable in assessing heart Nicolas Girerd, Jan Biegus, Adam Janas, Piotr Buszman, Marcin Suska, Ovidiu Chioncel, Julie Foucquier, Anne Llorca, Laura Cantu Sanchez, Marat Fudim, Kevin Damman, Maria Rosa Costanzo, Beth Davison, Gad Cotter, Laurent Sandrin, Victor de Lédinghen, Alexandre Mebazaa +16 morewiley +1 more sourcePrognostic value of NT‐proBNP in patients with primary mitral regurgitation undergoing transcatheter edge‐to‐edge repair
European Journal of Heart Failure, EarlyView.In the PRIME‐MR study, patients with higher N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) tertiles more frequently reached death or heart failure hospitalization (HFH) within 3 years. Log‐transformed NT‐proBNP levels independently predicted the primary endpoint (adjusted hazard ratio 1.17, 95% confidence interval 1.07–1.28; p < 0.001).Philipp von Stein, Jessica Weimann, Roman Pfister, Sebastian Ludwig, Benedikt Koell, Erwan Donal, Dhairya Patel, Lukas Stolz, Tetsu Tanaka, Andrea Scotti, Teresa Trenkwalder, Felix Rudolph, Daryoush Samim, Cristina Giannini, Julien Dreyfus, Jean‐Michel Paradis, Marianna Adamo, Nicole Karam, Yohann Bohbot, Anne Bernard, Bruno Melica, Angelo Quagliana, Yoan Lavie Badie, Mirjam Kessler, Omar Chehab, Simon Redwood, Edith Lubos, Lars Sondergaard, Marco Metra, Chiara Primerano, Fabien Praz, Muhammed Gerçek, Erion Xhepa, Georg Nickenig, Azeem Latib, Niklas Schofer, Raj Makkar, Juan F. Granada, Thomas Modine, Jörg Hausleiter, Augustin Coisne, Daniel Kalbacher, Christos Iliadis, on behalf of the PRIME‐MR Investigators, Paul Achouh, David Attias, Stephan Baldus, Alain Berrebi, Guillaume Bonnet, Laura Granada, Frederic Bouisset, Corentin Bourg, Thierry Bourguignon, Diogo Ferreira, Stéphane Lafitte, Thibault Lhermusier, Guillaume L'official, Mohammed Nejjari, Edoardo Pancaldi, Lydia X. Plewe, Tobias Rheude, Natacha Rousse, Volker Rudolph, Dan Rusinaru, Christophe Saint‐Etienne, Francisco Sampaio, Jury Schewel, Arnaud Sudre, Christophe Tribouilloy, Marcel Weber, Stephan Windecker +70 morewiley +1 more source